UK regulator reports rise in drug approvals and new AI healthcare regulations
read at raps ↗RegulatoryPositive
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) released its 2025-2026 annual report to Parliament.
The agency highlighted that it approved more new medicines in the past year than in the previous year, marking an uptick in approvals.
It also noted a record removal of illegal drugs from circulation and outlined steps to advance regulation of artificial intelligence in healthcare.
source
This writeup was produced by pharmadog from original reporting by raps.
Original headline: “Recon: BMS to construct AI supercomputer with Nividia; Tempus to acquire cancer diagnostic maker Personalis for $1.5B”
read at raps ↗68 words · retrieved Jul 21
comments(0)
5-min edit window · permanent after that